These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 138094)

  • 81. Attenuated glycogenolysis reduces glycolytic catabolite accumulation during ischemia in preconditioned rat hearts.
    Weiss RG; de Albuquerque CP; Vandegaer K; Chacko VP; Gerstenblith G
    Circ Res; 1996 Sep; 79(3):435-46. PubMed ID: 8781477
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacological effects of phosphatidylserine liposomes: regulation of gylcolysis and energy level in brain.
    Bigon E; Boarato E; Bruni A; Leon A; Toffano G
    Br J Pharmacol; 1979 Jun; 66(2):167-74. PubMed ID: 465867
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Altered proteoglycan synthesis by micromelial limbs induced by 6-aminonicotinamide. Appearance of abnormal forms of cartilage-characteristic proteoglycan (PG-H).
    Honda A; Kazuno S; Mori Y; Kimata K; Suzuki S
    Biochem J; 1987 Sep; 246(3):745-53. PubMed ID: 2961324
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Glucose metabolism in freshly isolated Müller glial cells from a mammalian retina.
    Poitry-Yamate CL; Tsacopoulos M
    J Comp Neurol; 1992 Jun; 320(2):257-66. PubMed ID: 1377718
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effects of 6-aminonicotinamide on abolition and induction of audiogenic seizures.
    Chen C; Gates GR
    Exp Neurol; 1977 Dec; 57(3):1049-53. PubMed ID: 144605
    [No Abstract]   [Full Text] [Related]  

  • 86. Metabolic alterations in Yoshida ascites tumour cells caused by 6-aminonicotinamide and prevented by nicotinamide.
    Ofori-Nkansah N; von Bruchhausen F
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(2):156-68. PubMed ID: 4258288
    [No Abstract]   [Full Text] [Related]  

  • 87. Effect of 6-aminonicotinamide on monoamine oxidase and Na+K+ATPase activity in different regions of rat brain.
    Mayanil CK; Kazmi SM; Baquer NZ
    Biochem Pharmacol; 1984 Oct; 33(19):3021-3. PubMed ID: 6091665
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Behaviour of the glycolytic system of rat brain and kidney in vivo after in hibition of the glucosephosphate isomerase. II. Substrate concentrations under the influence of ischemia, 6-aminonicotinamide, and 2-deoxyglucose.
    Keller K; Kolbe H; Lange K; Herken H
    Hoppe Seylers Z Physiol Chem; 1972 Sep; 353(9):1389-400. PubMed ID: 4264531
    [No Abstract]   [Full Text] [Related]  

  • 89. Role of glycogen in processes of cerebellar glial cells under conditions of its damage with sodium nitrite.
    Samosudova NV; Reutov VP; Larionova NP
    Bull Exp Biol Med; 2010 Dec; 150(2):247-50. PubMed ID: 21240384
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Distribution of 3 H-labelled 6-aminonicotinamide and accumulation of 6-phosphogluconate in the spinal cord.
    Meyer-Estorf G; Schulze PE; Herken H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(2):235-41. PubMed ID: 4268472
    [No Abstract]   [Full Text] [Related]  

  • 91. Energetic and morphological plasticity of C6 glioma cells grown on 3-D support; effect of transient glutamine deprivation.
    Martin M; Beauvoit B; Voisin PJ; Canioni P; Guérin B; Rigoulet M
    J Bioenerg Biomembr; 1998 Dec; 30(6):565-78. PubMed ID: 10206476
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Isolation and characterization of internalized glioma cell membranes.
    Lentzen H; Agrawal B; Noske W; Herken H
    Cell Tissue Res; 1984; 236(1):147-51. PubMed ID: 6713502
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Regulation of the pentose phosphate pathway in human astrocytes and gliomas.
    Loreck DJ; Galarraga J; Van der Feen J; Phang JM; Smith BH; Cummins CJ
    Metab Brain Dis; 1987 Mar; 2(1):31-46. PubMed ID: 3505333
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide.
    Jung W; Herken H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):424-32. PubMed ID: 2525671
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Glycolysis and glycogen metabolism after inhibition of hexose monophosphate pathway in C6-GLIAL cells.
    Keller K; Kolbe H; Herken H; Lange K
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):213-5. PubMed ID: 138094
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Glucose metabolism in C-1300 neuroblastoma cells after inhibition of hexose monophosphate pathway.
    Kolbe H; Keller K; Lange K; Herken H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):123-30. PubMed ID: 834312
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Decreased glycolytic flux rate in the isolated perfused rat brain after pretreatment with 6-aminonicotinamide.
    Krieglstein J; Stock R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):323-7. PubMed ID: 127127
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Spastic paresis after 6-aminonicotinamide: metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats.
    Herken H; Meyer-Estorf G; Halbhübner K; Loos D
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jun; 293(3):245-55. PubMed ID: 134291
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The effect of inhibition of hexosemonophosphate shunt on the metabolism of glucose and function in rat brain in vivo.
    Gaitonde MK; Evans GM
    Neurochem Res; 1982 Sep; 7(9):1163-79. PubMed ID: 6217428
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.